FMR1 alleles in Tasmania: A screening study of the special educational needs population

Clinical Genetics

Volumn 67, Issue 1, 2005, Pages 38-46

  Mitchell, R John ^a   Holden, J J A ^b   Zhang, C ^b   Curlis, Y ^a   Slater, H R ^c   Burgess, T ^c   Kirkby, K C ^d   Carmichael, A ^d   Heading, K D ^d   Loesch, D Z ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b QUEEN S UNIVERSITY   (Canada)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Distribution of FMR1 alleles; Fragile X; Grey zone alleles; Special educational needs; Transmission stability

Indexed keywords

CYTOSINE; DNA; FRAGILE X MENTAL RETARDATION PROTEIN; GUANINE;

ALLELE; ARTICLE; AUSTRALIA; BLOOD SAMPLING; CAUCASIAN; CONTROLLED STUDY; EDUCATION; FRAGILE X SYNDROME; FREQUENCY ANALYSIS; GENE FREQUENCY; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; TRINUCLEOTIDE REPEAT; VENOUS BLOOD;

ADOLESCENT; ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; EDUCATION, SPECIAL; EPIDEMIOLOGY, MOLECULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOUNDER EFFECT; FRAGILE X MENTAL RETARDATION PROTEIN; GENE FREQUENCY; GENETIC SCREENING; HUMANS; MALE; NEEDS ASSESSMENT; NERVE TISSUE PROTEINS; RNA-BINDING PROTEINS; TASMANIA; TRINUCLEOTIDE REPEATS;

EID: 19944434117     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2004.00344.x     Document Type: Article

References (59)

1. Verkerk AJMH, Pieretti M, Sutcliffe JS et al. Identification of a gene (FMR1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991: 65: 905-914.
2. Sherman S. Epidemiology. In: Fragile X syndrome: diagnosis, treatment and research, 3rd edn. (Hagerman RJ, Hagerman PJ, eds). Baltimore: The Johns Hopkins University Press, 2002: 136-168.
3. Li Z, Zhang Y, Ku L et al. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res 2001: 29: 2276-2283.
4. Comery TA, Harris JB, Willems PJ et al. Abnormal dendritic spines in fragile X knockout mouse: maturation and pruning deficits. Proc Nat Acad Sci USA 1997: 94: 5401-5404.
5. Eichler EE, Holden JJA, Popovich BW et al. Length of uninterrupted CGG repeats determines instability in the FMR-1 gene. Nat Genet 1994: 8: 88-94.
6. Hirst MC, Arinami T, Laird CD. Sequence analysis of long FMR1 arrays in the Japanese population: insights into the generation of long (CGG)n tracts. Hum Genet 1997: 101: 214-218.
7. Kunst CB, Warren S. Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles. Cell 1994: 77: 853-861.
8. Rousseau FD, Heitz D, Biancalana V et al. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med 1991: 325: 1673-1681.
9. Pieretti M, Zhang FP, Fu YH et al. Absence of expression of the FMR1 gene in fragile X syndrome. Cell 1991: 66: 817-822.
10. Hagerman RJ. The physical and behavioral phenotype. In: Fragile X syndrome: diagnosis, treatment and research, 3rd edn. (Hagerman RJ, Hagerman PJ, eds). Baltimore: The Johns Hopkins University Press, 2002: 3-109.
11. Youings SA, Murray A, Dennis N et al. FRAXA and FRAXE; the results of a five year study. J Med Genet 2002: 37: 415-421.
12. Fu YH, Kuhl DPA, Pizzuti A et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991: 67: 1047-1058.
13. Maddalena A, Richards CS, McGinniss MJ et al. Technical standards and guidelines for fragile X: the first of a series of disease specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee Laboratory Practice Committee. Genet Med 2001: 3: 200-205.
14. Dombrowski C, Lévesque S, Morel ML et al. Premutation and intermediate-size FMR1 alleles in 10572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet 2002: 11: 371-378.
15. Heitz D, Devys D, Imbert G et al. Inheritance of the fragile X syndrome: size of the fragile X premutation is a major determinant of the transition to full mutation. J Med Genet 1992: 29: 794-801.
16. Loesch DZ, Hay DA, Mulley J. Transmitting males and carrier females in fragile X revisited. Am J Med Genet 1994: 51: 392-399.
17. Sobesky WE, Taylor AK, Pennington BF et al. Molecular/clinical correlations in females with fragile X. Am J Med Genet 1996: 64: 340-345.
18. Franke P, Leboyer M, Gansicke M et al. Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Res 1998: 80: 113-127.
19. Riddle JE, Cheema A, Sobesky WE et al. Phenotypic involvement in females with the FMR1 gene mutation. Am J Ment Retard 1998: 102: 590-601.
20. Johnston C, Eliez S, Dyer-Friedman J et al. Neurobehavioral phenotype in carriers of fragile X permutation. Am J Med Genet 2001: 103: 314-319.
21. Loesch DZ, Huggins RM, Bui QM et al. Relationship of deficits of FMR1 gene specific protein with physical phenotype of fragile X males and females in pedigrees: a new perspective. Am J Med Genet 2003a: 118A (2): 127-134.
22. Loesch DZ, Huggins RM, Butler E et al. Effect of the fragile X status categories on cognitive profiles of fragile X males and females assessed by robust pedigree analysis. Am J Med Genet 2003b: 122A: 13-23.
23. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D et al. Fragile X premutation is a significant risk factor for premature ovarian failure. The international collaborative POF in fragile X study - preliminary data. Am J Med Genet 1999: 83: 322-325.
24. Hagerman RJ, Leehey M, Heinrichs W et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001: 57: 127-130.
25. Crawford DC, Meadows KL, Newman JL et al. Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large ethnically diverse, special education-needs population. Am J Hum Genet 1999: 64: 495-507.
26. Patsalis PC, Sismani C, Hettinger JA et al. Frequencies of 'grey-zone' and premutation-sized FMR1 CGG-repeat alleles in patients with developmental disability in Cyprus and Canada. Am J Med Genet 1999: 84: 195-197.
27. Murray A, Youings S, Dennis N et al. Population screening at the FRAXA and FRAXE loci: molecular analysis of boys with learning difficulties and their mothers. Hum Mol Genet 1996: 5: 727-735.
28. Haddad LA, Aguiar MJ, Costa SS et al. Fully mutated and gray-zone FRAXA alleles in Brazilian mentally retarded boys. Am J Med Genet 1999: 84: 198-201.
29. Mazzocco MM, Sonna NL, Teisl JT et al. The FMR1 and FMR2 mutations are not common etiologies of academic difficulty among school age children. J Dev Behav Pediatr 1997: 18: 392-398.
30. Mazzocco MM, Myers GF, Hamner JL et al. The prevalence of the FMR1 and FMR2 mutations among preschool children with language delay. J Pediatr 1998: 132: 795-801.
31. Mornet E, Simon-Bouy B, Serre JL. The intermediate alleles of the fragile X CGG repeat in patients with mental retardation. Clin Genet 1998: 53: 200-201. [abstract]
32. Castellvi-Bel S, Fernandez-Burriel M, Rife M et al. Detection of the fragile X syndrome protein for the evaluation of FMR1 intermediate alleles. Hum Genet 2000: 107: 195-196.
33. Kenneson A, Zhang F, Hagedorn CH et al. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate length and premutation carriers. Hum Mol Genet 2001: 10: 1449-1454.
34. Rubio JP, Bahlo M, Butzkueven H et al. Genetic dissection of the human leucocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. Am J Hum Genet 2002: 70: 1125-1137.
35. Zhong N, Kajanoja E, Smits B et al. Fragile X founder effects and new mutations in Finland. Am J Med Genet 1996a: 64: 226-233.
36. Oudet C, Koskull H, Nordstrom AM et al. Striking founder effect for the fragile X syndrome in Finland. Eur J Hum Genet 1993a: 1: 181-189.
37. Bonaventure G, Torrado M, Barriero C, Chertkoff L. Fragile X founder effects in Argentina. Am J Med Genet 1998: 79: 200-204.
38. Richards RI, Holman K, Kozman H et al. Fragile X syndrome: genetic localization by linkage mapping of two microsatellite repeats FRAXAC1 and FRAXAC2 which immediately flank the fragile site. J Med Genet 1991: 28: 818-823.
39. Gunter C, Paradee W, Crawford W et al. Re-examination of factors associated with expansion of CGG repeat using a single nucleotide polymorphism in FMR1. Hum Mol Genet 1998: 77: 1935-1946.
40. Zhong N, Ju W, Pietrofesa J et al. Fragile X 'gray' zone alleles: AGG patterns, expansion risks, and associated haplotypes. Am J Hum Genet 1996: 64: 261-265.
41. Curlis Y, Zhang C, Holden JJA et al. A haplotype study of grey zone alleles at the fragile X (FMR1) gene: ATL1, FMRb and microsatellite haplotypes differ from those found in common FMR1 alleles. Hum Biol (in press).
42. Holden JJA, Chalifoux M, Wing M et al. A rapid, reliable, and inexpensive method for the detection of di- and trinucleotide repeat markers and disease loci from dried blood spots. Am J Med Genet 1996: 64: 313-318.
43. Yu S, Pritchard M, Kremer E et al. Fragile X genotype characterized by an unstable region of DNA. Science 1991: 252: 1179-1181.
44. Oudet C, Mornet E, Serre JL et al. Linkage disequilibrium between the fragile X mutation and two closely linked CA repeats suggests that fragile X chromosomes are derived from a mall number of founder chromosomes. Am J Hum Genet 1993b: 52: 297-304.
45. Chiurazzi P, Pomponi MG, Sharrock A et al. DNA panel for interlaboratory standardization of haplotype studies on the fragile X syndrome and proposal for a new nomenclature. Am J Med Genet 1999: 83: 347-349.
46. Lachin JM. Biostatistical methods. New York: Wiley & Sons, 2000.
47. Mitchell RJ, Izatt MM. Gm and Km allotypes in Tasmania. Human Biol 1981: 53: 467-477.
48. Mitchell RJ. Red cell antigen, plasma protein, and red cell enzyme polymorphism in the island of Tasmania. Human Heredity 1983: 33: 181-184.
49. Mitchell RJ, Kosten M, Williams J. Historical demography and genetic structure of Tasmania. In: Epidemiology in Tasmania (King H ed). Canberra: Brolga Press, 1987: 1-21.
50. Brown WT, Nolin S, Houck G Jr et al. Prenatal diagnosis and carrier screening for fragile X by PCR. Am J Med Genet 1996: 64: 191-195.
51. Holden JJA, Chalifaux M, Wing M et al. Distribution and frequency of FMR1 CGG repeat numbers in the general population. Dev Brain Dysfunct 1995: 8: 405-407.
52. Dawson AJ, Chodirker BN, Chudley AE. Frequency of FMR1 premutations in a consecutive newborn population by PCR screening of Guthrie blood spots. Biochem Mol Med 1995: 56: 63-69.
53. Rife M, Badenas C, Mallolas J et al. Incidence of fragile X consecutive newborn males. Genet Test 2003: 7: 339-343.
54. Eichler EE, Macpherson JN, Murray A et al. Haplotype and interspersion analysis of the FMR1 CGG repeat identifies two different mutational pathways for the origin of the fragile X syndrome. Hum Mol Genet 1996: 5: 319-330.
55. Turner G, Webb S, Wake S, Robinson H. Prevalence of fragile X syndrome. Am J Med Genet 1996: 65: 196-197.
56. Tranebjaerg L, Hilling S, Jessen J et al. Prevalence of fra(X) in the county of Funen in Denmark is lower than expected. Am J Med Genet 1994: 51: 423-427.
57. Beresford RG, Tatlidil C, Riddell DC et al. Absence of fragile X syndrome in Nova Scotia. J Med Genet 2000: 37: 77-79.
58. Murray A, Macpherson JN, Pound MC et al. The role of size, sequence and haplotype in the stability of FRAXA and FRAXE alleles during transmission. Hum Mol Genet 1997: 6: 173-184.
59. Sullivan AK, Crawford DC, Scott EH et al. Paternally transmitted FMR1 alleles are less stable than maternally transmitted alleles in the common and intermediate size range. Am J Hum Genet 2002: 70: 1532-1544.